MiniMed (MMED) Gross Margin (2025 - 2026)
MiniMed (MMED) posted Gross Margin of 57.35% for Q2 2026, up 25.15% on a QoQ basis from 45.82% in Q1 2026, and up 141.0% year-over-year from 23.8% in Q2 2025.
MiniMed (MMED) Gross Margin (2025 - 2026) Analysis & Trends
MiniMed's Gross Margin history runs 2 years deep, the most recent figure standing at 57.35% for Q2 2026.
- Quarterly Gross Margin rose 141.0% year-over-year to 57.35% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 54.05% (changed N/A YoY) and the FY2026 annual result came in at 54.16%, down 212.0% from the prior year.
- Gross Margin was 57.35% for Q2 2026 at MiniMed, up from 45.82% in the prior quarter.
- Across five years, Gross Margin topped out at 57.5% in Q1 2025 and bottomed at 45.82% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.90 Bn | 24.59 Bn | 662.02 Mn | 74.98% |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | 13.34% |
| 3 | Healthequity | 8.31 Bn | 8.04 Bn | 256.31 Mn | 72.27% |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | 84.60% |
| 5 | 10x Genomics | 5.84 Bn | 5.30 Bn | 106.18 Mn | 70.39% |
| 6 | Waystar Holding | 4.49 Bn | 4.42 Bn | 216.84 Mn | 69.08% |
| 7 | MiniMed | 4.47 Bn | 4.17 Bn | 480.00 Mn | 57.35% |
| 8 | Doximity | 3.96 Bn | 3.22 Bn | 125.97 Mn | 86.65% |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - | - |
| 10 | Omnicell | 1.86 Bn | 1.62 Bn | 140.36 Mn | 45.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 57.35% |
| Jan 23, 2026 | 45.82% |
| Apr 25, 2025 | 55.94% |
| Jan 24, 2025 | 57.50% |